Skip To Main Content
Alan W. Pollack on Muck Rack

Alan W. Pollack

As seen in: Nature, The Lancet, rug.nl, HemOnc Today, Journal of Clinical Oncology, Augusta Free Press, European Urology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alan W.

Contact Alan W., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials - European Urology

|
By Todd Morgan, Yi Ren, Siyi Tang, Wouter Zwerink, Emmalyn Chen, Akinori Mitani, Huei-Chung Huang, Jeffry Simko, Sandy DeVries, Alan W. Pollack, Derek Wilke, André-Guy Martin, Alexander Balogh, Jeff M. Michalski, Michael Greenberg, Jason A. Efstathi
| European Urology Verified
Keywords Artificial intelligence Digital pathology Prostate cancer Radical prostatectomy Salvage therapy Prognostic model What does this study add? A novel digital pathology–based multimodal artificial intelligence (MMAI) biomarker was developed to predict long-term outcomes in men with biochemical recurrence (BCR) following radical prostatectomy (RP).
Open in Who Shared Issue with article?

The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors’ reply

|
By Alan W. Pollack, Theodore Karrison, NRG Oncology, Felix Feng
| The Lancet Verified
We appreciate the comments of Pirus Ghadjar and colleagues and Pervin Hurmuz and colleagues on some unaddressed issues raised by the SPPORT trial. Patients were eligible for the SPPORT trial 1 Pollack A Karrison TG Balogh AG et al. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Open in Who Shared Issue with article?

The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy

|
By Alan W. Pollack
| pdf2html.opoint.com
Correspondence www.thelancet.com Vol 400   September 10, 2022 885 1 Pollack A, Karrison TG, Balogh AG, et al. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/ RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial. Lancet 2022; 399: 1886–901. 2 Murthy V, Maitre P, Kannan S, et al.
Open in Who Shared Issue with article?
See all 26 articles